Bottom line
Is MIMSX a good fund? The bottom line
MIMSX is the Investor share class of BNY Mellon Mid Cap Multi-Strategy Fund, an actively managed alternatives mutual fund from BNY Mellon / Dreyfus.
Annual fees run 1.2% — about $120 a year on every $10,000 invested, cheaper than 67% of alternatives funds we track.
It returned +12.4% over one year, +9.4% a year over five years, +9.0% a year over ten (as of Dec 31, 2024, per its prospectus).
What stands out
- 5-year return beat 86% of category peers
Updated Nov 19, 2026
What MIMSX invests in
The fund seeks capital appreciation.
"To pursue its goal, the fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of mid cap companies. The fund currently considers mid cap companies to be those companies with market capitalizations that are within the market capitalization range of companies comprising the Russell Midcap Index. As of November 30, 2025, the market capitalizations of the largest and smallest companies in the Russell Midcap Index were approximately $114.5 billion and $1.0 billion, respectively, and the weighted average and median market capitalizations of the index were approximately $30.7 billion and $12.3 billion, respectively. The fund normally allocates its assets among multiple investment strategies employed by BNY Mellon Investment Adviser, Inc. (BNYIA) and affiliated and unaffiliated sub-advisers that invest primarily in equity…
From the fund's prospectus (filed Dec 29, 2025).
MIMSX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| MIMSX | +12.4% | +9.4% | +9.0% |
| Alternatives median | +7.4% | +4.2% | +3.8% |
Source: Fund prospectus, as of Dec 31, 2024
What MIMSX costs
On a $10,000 investment, MIMSX's 1.2% expense ratio costs about $120 a year. The median alternatives fund charges 1.54%.